LESLEY KLUG: Open Payments
NPI 1760561328 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,131 in 29 payments from 15 companies in 2025. Trend: 2023 $667 · 2024 $1,019 · 2025 $1,131
Food & beverage: $982Education: $149
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 5 | $273 |
| Stemline Therapeutics Inc. | 4 | $260 |
| Eisai Inc. | 1 | $120 |
| Aveo Pharmaceuticals, Inc. | 2 | $113 |
| Janssen Scientific Affairs, LLC | 1 | $110 |
| Astellas Pharma US Inc | 3 | $54 |
| ABBVIE INC. | 2 | $52 |
| Janssen Biotech, Inc. | 4 | $43 |
| Genentech USA, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: Orserdu, Enhertu, DATROWAY, Lenvima, FOTIVDA, ERLEADA, Vyloy, Epkinly.
Industry payments across NE — which companies pay providers there.
